Fractalkine promotes chemotaxis of bone marrow-derived mesenchymal stem cells towards ischemic brain lesions through Jak2 signaling and cytoskeletal reorganization

FEBS Journal

Volumn 282, Issue 5, 2015, Pages 891-903

  Zhang, Yuan ^a   Zheng, Jian ^a   Zhou, Zhujuan ^a   Zhou, Huadong ^b   Wang, Yanjiang ^b   Gong, Zili ^a   Zhu, Jie ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

bone marrow derived mesenchymal stem cells; chemotaxis; cytoskeleton; fractalkine; Jak2

Indexed keywords

FRACTALKINE; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PAIRED BOX TRANSCRIPTION FACTOR; STAT5A PROTEIN; VERY LATE ACTIVATION ANTIGEN 5; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, HUMAN; CX3CL1 PROTEIN, RAT; CX3CR1 PROTEIN, HUMAN; CX3CR1 PROTEIN, RAT; JAK2 PROTEIN, RAT; STAT5 PROTEIN; STAT5A PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN ISCHEMIA; CHEMOTAXIS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BONE MARROW; CELL CULTURE; CELL MOTION; CEREBRAL INFARCTION; CYTOLOGY; GENETICS; HEK293 CELL LINE; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; ULTRASTRUCTURE; WISTAR RAT;

RATTUS;

ANIMALS; BONE MARROW; BRAIN ISCHEMIA; CELL MOVEMENT; CELLS, CULTURED; CEREBRAL INFARCTION; CHEMOKINE CX3CL1; CHEMOTAXIS; CYTOSKELETON; HEK293 CELLS; HUMANS; JANUS KINASE 2; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS, WISTAR; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84923915060     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13187     Document Type: Article

References (30)

1. Agulla J, Brea D, Campos F, Sobrino T, Argibay B, Al-Soufi W, Blanco M, Castillo J, &, Ramos-Cabrer P, (2014) In vivo theranostics at the peri-infarct region in cerebral ischemia. Theranostics 4, 90-105.
2. Huang X, Sun J, Zhao T, Wu KW, Watanabe K, Xiao ZC, Zhu LL, &, Fan M, (2011) Loss of NB-3 aggravates cerebral ischemia by impairing neuron survival and neurite growth. Stroke 42, 2910-2916.
3. Gan Y, Liu Q, Wu W, Yin JX, Bai XF, Shen R, Wang Y, Chen J, La Cava A, Poursine-Laurent J, et al,. (2014) Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A 111, 2704-2709.
4. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, et al,. (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9, 917-924.
5. Savarin-Vuaillat C, &, Ransohoff RM, (2007) Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurotherapeutics 4, 590-601.
6. Lee SJ, Namkoong S, Kim YM, Kim CK, Lee H, Ha KS, Chung HT, Kwon YG, &, Kim YM, (2006) Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am J Physiol Heart Circ Physiol 291, H2836-H2846.
7. Marchesi F, Locatelli M, Solinas G, Erreni M, Allavena P, &, Mantovani A, (2010) Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer. J Neuroimmunol 224, 39-44.
8. Okano H, (2011) Strategic approaches to regeneration of a damaged central nervous system. Cornea 30, S15-S18.
9. Tei N, Tanaka J, Sugimoto K, Nishihara T, Nishioka R, Takahashi H, Yano H, Matsumoto S, Ohue S, Watanabe H, et al,. (2013) Expression of MCP-1 and fractalkine on endothelial cells and astrocytes may contribute to the invasion and migration of brain macrophages in ischemic rat brain lesions. J Neurosci Res 91, 681-693.
10. Wang Y, Deng Y, &, Zhou GQ, (2008) SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 1195, 104-112.
11. Ji JF, He BP, Dheen ST, &, Tay SS, (2004) Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22, 415-427.
12. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, et al,. (2009) Pivotal role of cerebral interleukin-17-producing gammadelta T cells in the delayed phase of ischemic brain injury. Nat Med 15, 946-950.
13. Catalano M, Lauro C, Cipriani R, Chece G, Ponzetta A, Di Angelantonio S, Ragozzino D, &, Limatola C, (2013) CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes. J Neuroimmunol 263, 75-82.
14. Zhu J, Zhou Z, Liu Y, &, Zheng J, (2009) Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats. Brain Res 1287, 173-183.
15. Sheridan GK, &, Murphy KJ, (2013) Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage. Open Biol 3, 130181.
16. MacLellan CL, Auriat AM, McGie SC, Yan RH, Huynh HD, De Butte MF, &, Colbourne F, (2006) Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies. J Cereb Blood Flow Metab 26, 1031-1042.
17. Hanisch UK, &, Kettenmann H, (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10, 1387-1394.
18. Liu Y, Zhao T, Yang Z, &, Li Q, (2014) CX3CR1 RNAi inhibits hypoxia-induced microglia activation via p38MAPK/PKC pathway. Int J Exp Pathol 95, 153-157.
19. Gevrey JC, Isaac BM, &, Cox D, (2005) Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). J Immunol 175, 3737-3745.
20. Cambien B, Pomeranz M, Schmid-Antomarchi H, Millet MA, Breittmayer V, Rossi B, &, Schmid-Alliana A, (2001) Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97, 2031-2037.
21. Yang XP, Mattagajasingh S, Su S, Chen G, Cai Z, Fox-Talbot K, Irani K, &, Becker LC, (2007) Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway. Circ Res 101, 1001-1008.
22. Gao H, Priebe W, Glod J, &, Banerjee D, (2009) Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 27, 857-865.
23. Huttenlocher A, &, Horwitz AR, (2011) Integrins in cell migration. Cold Spring Harb Perspect Biol 3, a005074.
24. Millard M, Odde S, &, Neamati N, (2011) Integrin targeted therapeutics. Theranostics 1, 154-188.
25. Lauro C, Catalano M, Trettel F, Mainiero F, Ciotti MT, Eusebi F, &, Limatola C, (2006) The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the beta1 integrin subunit. J Immunol 177, 7599-7606.
26. Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E, Perego C, De Simoni MG, Fredholm BB, Eusebi F, et al,. (2011) CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci 31, 16327-16335.
27. Donohue MM, Cain K, Zierath D, Shibata D, Tanzi PM, &, Becker KJ, (2012) Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke. Stroke 43, 2300-2306.
28. Dénes A, Ferenczi S, Halász J, Környei Z, &, Kovács KJ, (2008) Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab 28, 1707-1721.
29. Fumagalli S, Perego C, Ortolano F, &, De Simoni MG, (2013) CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 61, 827-842.
30. Zhou Z, Xu Y, Zhong Q, &, Zheng J, (2012) Phenotypic characteristics of hybrid cells generated by transferring neuronal nuclei into bone marrow stromal cell cytoplasts. Brain Res Bull 87, 303-311.